Dr. Grischa Judanin, MD

Grischa Judanin is a physician, entrepreneur, and leading voice in the field of medical cannabis and digital health. As the Founder and CEO of 5SWAN, a pioneering telemedicine platform, he has helped redefine access to evidence-based cannabinoid therapy through structured, physician-led care. With his background in medicine and extensive expertise in chronic-care models, he focuses on combining rigorous clinical standards with scalable digital pathways to improve the quality of life for patients who lack adequate access to specialized care. Under his leadership, 5SWAN has become recognized for its high-quality clinical protocols, German-licensed medical staff, and its strong emphasis on patient safety, outcome tracking, and ongoing therapeutic monitoring.

Judanin’s work centers on integrating emerging cannabinoid science into real-world medical practice. He is actively involved in national discussions on telemedicine regulation, cannabis policy, and long-term treatment outcomes, collaborating with pharmacists, physicians, and healthcare innovators across Germany. As a sought-after expert, he regularly contributes reviews and scientific assessments aimed at improving clinical understanding of THC, CBD, and novel cannabinoids. His mission is to make modern, compassionate, and evidence-driven cannabinoid medicine accessible to all patients who may benefit.